Skye Bioscience, Inc. (SKYE) - Latest Market Data

Price & Market Data

Price: $0.84

Daily Change: +$0.125 / 14.92%

Daily Range: $0.71 - $0.841

Market Cap: $29,144,686

Daily Volume: 233,502

Performance Metrics

1 Week: -13.26%

1 Month: -9.65%

3 Months: -4.48%

6 Months: -39.63%

1 Year: -65.54%

YTD: 3.23%

About Skye Bioscience, Inc. (SKYE)

Understand Skye Bioscience, Inc. (SKYE)'s current market standing. Current price: 0.84, daily change: +$0.125 / 14.92%. Market cap: 29,144,686. Detailed performance for all periods.

Company Details

Employees: 12

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.

Selected stocks

Paranovus Entertainment Technology Ltd. (PAVS)

Gaotu Techedu Inc. (GOTU)

VolitionRX Limited (VNRX)

OnKure Therapeutics, Inc. (OKUR)